KRISTJAN ROKO: Open Payments
NPI 1083339329 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,746 in 91 payments from 22 companies in 2025. Trend: 2023 $1,728 · 2024 $1,849 · 2025 $2,746
Food & beverage: $2,746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $741 |
| Novo Nordisk Inc | 13 | $379 |
| ABBVIE INC. | 5 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $192 |
| Phathom Pharmaceuticals, Inc. | 5 | $184 |
| Novartis Pharmaceuticals Corporation | 6 | $138 |
| Eisai Inc. | 1 | $122 |
| Amgen Inc. | 6 | $111 |
| Corcept Therapeutics | 5 | $101 |
| PFIZER INC. | 4 | $85 |
Products named: AIRSUPRA, FARXIGA, Ozempic, CAPLYTA, VOQUEZNA, VRAYLAR, LEQVIO, Leqembi.
Industry payments across FL — which companies pay providers there.
